These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16039316)

  • 21. Syringe exchange proposal.
    Jacobs RE
    N J Med; 2002 Dec; 99(12):33-4. PubMed ID: 12510571
    [No Abstract]   [Full Text] [Related]  

  • 22. The force of numbers: why hepatitis C is spreading among Australian injecting drug users while HIV is not.
    Sullivan LG
    Med J Aust; 1999 Aug; 171(3):165-6. PubMed ID: 10474613
    [No Abstract]   [Full Text] [Related]  

  • 23. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Science versus politics: the need for supervised injection facilities in Montreal, Canada.
    Jozaghi E
    Int J Drug Policy; 2012 Sep; 23(5):420-1. PubMed ID: 22818890
    [No Abstract]   [Full Text] [Related]  

  • 25. NIH report.
    Makulowich GS
    AIDS Patient Care STDS; 1998 Feb; 12(2):151. PubMed ID: 11361922
    [No Abstract]   [Full Text] [Related]  

  • 26. CLINICAL VIEW ON SUBSTANCE-INDUCED PSYCHOTIC SYMPTOMS IN A MEDICALLY SUPERVISED INJECTING ROOM: A DECADE OF EXPERIENCE.
    Palma-Álvarez RF; Daigre C; Ballabriga-Córdoba T; Monterde-Ochoa E; Sierra-Fortuny M; Cantillo M; Pelaez M; Castrillo E; Camañes L; Roncero C; Ramos-Quiroga JA; Grau-López L
    Actas Esp Psiquiatr; 2023 Jul; 51(4):188-191. PubMed ID: 37817739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conservative government scuttles needle exchange.
    Kondro W
    CMAJ; 2007 Jan; 176(3):308. PubMed ID: 17261817
    [No Abstract]   [Full Text] [Related]  

  • 28. Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs.
    Ward J; Topp L; Iversen J; Wand H; Akre S; Kaldor J; Maher L
    Aust N Z J Public Health; 2011 Oct; 35(5):421-6. PubMed ID: 21973248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Needle exchange: why don't the feds get the point?
    Beaubien G
    Posit Aware; 1997; 8(2):36-40. PubMed ID: 11364456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring effectiveness of needle and syringe exchange programmes for prevention of HIV among injecting drug users.
    Amundsen EJ
    Addiction; 2006 Jul; 101(7):911-2. PubMed ID: 16771880
    [No Abstract]   [Full Text] [Related]  

  • 31. Risk, shame and the public injector: a qualitative study of drug injecting in South Wales.
    Rhodes T; Watts L; Davies S; Martin A; Smith J; Clark D; Craine N; Lyons M
    Soc Sci Med; 2007 Aug; 65(3):572-85. PubMed ID: 17475383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Public injection settings in Vancouver: physical environment, social context and risk.
    Small W; Rhodes T; Wood E; Kerr T
    Int J Drug Policy; 2007 Jan; 18(1):27-36. PubMed ID: 17689341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney.
    Bryant J; Topp L; Hopwood M; Iversen J; Treloar C; Maher L
    Drug Alcohol Rev; 2010 Jul; 29(4):364-70. PubMed ID: 20636651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safer injecting facilities-is the research there? A comment on Caulkins et al. (2019).
    Belackova V; Salmon AM; Jauncey M; Day CA
    Addiction; 2020 Apr; 115(4):784-785. PubMed ID: 31692143
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV vaccines for injection drug users in the context of a comprehensive prevention agenda.
    Vlahov D
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S3-6. PubMed ID: 7865324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug use settings: an emerging focus for research and intervention.
    Kerr T; Kimber J; Rhodes T
    Int J Drug Policy; 2007 Jan; 18(1):1-4. PubMed ID: 17689337
    [No Abstract]   [Full Text] [Related]  

  • 37. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
    Day C; Conroy E; Lowe J; Page J; Dolan K
    Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Injecting drug use in Australia: needle/syringe programs prove their worth, but hepatitis C still on the increase.
    Copeman M
    Med J Aust; 2003 Jul; 179(2):119; author reply 119. PubMed ID: 12864712
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004.
    Falster K; Kaldor JM; Maher L;
    J Urban Health; 2009 Jan; 86(1):106-18. PubMed ID: 18979201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.
    Mahanta J; Medhi GK; Paranjape RS; Roy N; Kohli A; Akoijam BS; Dzuvichu B; Das HK; Goswami P; Thongamba G;
    AIDS; 2008 Dec; 22 Suppl 5():S59-68. PubMed ID: 19098480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.